These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines. Klasse PJ; Moore JP Retrovirology; 2012 Oct; 9():80. PubMed ID: 23025660 [TBL] [Abstract][Full Text] [Related]
6. AIDS vaccine shows promise after years of frustration. Cohen J Science; 2001 Mar; 291(5509):1686-8. PubMed ID: 11263450 [No Abstract] [Full Text] [Related]
7. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159 [TBL] [Abstract][Full Text] [Related]
8. AIDS research. Merck reemerges with a bold AIDS vaccine effort. Cohen J Science; 2001 Apr; 292(5514):24-5. PubMed ID: 11294193 [No Abstract] [Full Text] [Related]
9. Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates. Warren J J Med Primatol; 2002 Aug; 31(4-5):237-56. PubMed ID: 12390546 [TBL] [Abstract][Full Text] [Related]
10. Working group consultation: alloimmunity as a vaccine approach against HIV/AIDS: National Institutes of Health Meeting Report, May 24, 2012. Singh A; Warren J; Schultz A; Hackett CJ; Sharma O AIDS Res Hum Retroviruses; 2013 Jun; 29(6):851-8. PubMed ID: 23530996 [TBL] [Abstract][Full Text] [Related]
11. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS. Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236 [TBL] [Abstract][Full Text] [Related]
12. Vaccinology: Persistence pays off. Johnson RP Nature; 2011 May; 473(7348):456-7. PubMed ID: 21614068 [TBL] [Abstract][Full Text] [Related]
13. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge. Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection. Geretti AM; Hulskotte E; Osterhaus AD J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818 [No Abstract] [Full Text] [Related]
15. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines. Staprans SI; Feinberg MB Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S5-32. PubMed ID: 15285703 [TBL] [Abstract][Full Text] [Related]
16. Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones. Lifson JD; Haigwood NL Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007310. PubMed ID: 22675663 [TBL] [Abstract][Full Text] [Related]
17. Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS. Shearer GM; Pinto LA; Clerici M Immunol Today; 1999 Feb; 20(2):66-71. PubMed ID: 10098324 [TBL] [Abstract][Full Text] [Related]